Reata Pharmaceuticals Inc buy melinda
Start price
21.10.17
/
50%
?32.73
Target price
06.12.17
€35.00
Performance (%)
-30.35%
End price
06.12.17
€22.80
Summary
This prediction ended on 06.12.17 with a price of €22.80. Massive losses of -30.35% were the result for the BUY prediction by melinda. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Reata Pharmaceuticals Inc | - | - | - | - |
| iShares Core DAX® | 1.001% | -1.218% | 13.263% | 60.023% |
| iShares Nasdaq 100 | -1.447% | -4.597% | 0.414% | 85.321% |
| iShares Nikkei 225® | 8.406% | 8.425% | 27.328% | 61.038% |
| iShares S&P 500 | -0.226% | -2.451% | 0.167% | 57.738% |
Comments by melinda for this prediction
In the thread Reata Pharmaceuticals Inc diskutieren
Reata Pharmaceuticals, Inc.
Reata kündigt Ende der Präsentation der wichtigsten Ergebnisse der Phase - 2 - Studie KARDINAL während der 2017 Jahrestagung der American Society of Nephrology
(Vom Mitglied beendet)
Stopped prediction by melinda for Reata Pharmaceuticals Inc
Reata Pharmaceuticals Inc
Start price
Target price
Perf. (%)
?84.56
03.04.19
03.04.19
€92.00
04.11.19
04.11.19
0.00%
04.11.19
04.11.19
Reata Pharmaceuticals Inc
Start price
Target price
Perf. (%)
?88.32
27.02.19
27.02.19
€90.20
04.03.19
04.03.19
2.32%
04.03.19
04.03.19
Reata Pharmaceuticals Inc
Start price
Target price
Perf. (%)
?59.89
23.07.18
23.07.18
€63.14
25.07.18
25.07.18
12.39%
25.07.18
25.07.18
Reata Pharmaceuticals Inc
Start price
Target price
Perf. (%)
?29.52
21.10.17
21.10.17
€31.57
06.12.17
06.12.17
-30.35%
06.12.17
06.12.17